The Regional Innovative Public Health Laboratory will collect and analyze COVID-19 samples from hospitals across Chicago to study. The goal is to detect new virus strains and learn which existing strains are spreading where to aid public health efforts to control the city’s outbreak.
Chicago-based Rush won the contract in December and announced the effort Feb. 11. The medical center said the lab should be fully operational by March.
More articles on public health:
All 50 states report minimal flu activity for 2nd week in row: 6 CDC FluView takeaways
12 weekly COVID-19 stats from the CDC
COVID-19 death rates by state: Feb. 15
